Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2003-5-13
pubmed:abstractText
We sought to investigate whether the activation of the chemokine network observed in patients with coronary artery disease (CAD) could be modified by treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0735-1097
pubmed:author
pubmed:issnType
Print
pubmed:day
7
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1460-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12742282-Adult, pubmed-meshheading:12742282-Aged, pubmed-meshheading:12742282-Chemokines, pubmed-meshheading:12742282-Coronary Artery Disease, pubmed-meshheading:12742282-Dose-Response Relationship, Drug, pubmed-meshheading:12742282-Down-Regulation, pubmed-meshheading:12742282-Female, pubmed-meshheading:12742282-Follow-Up Studies, pubmed-meshheading:12742282-Heptanoic Acids, pubmed-meshheading:12742282-Humans, pubmed-meshheading:12742282-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:12742282-Leukocytes, Mononuclear, pubmed-meshheading:12742282-Male, pubmed-meshheading:12742282-Middle Aged, pubmed-meshheading:12742282-Pyrroles, pubmed-meshheading:12742282-RNA, Messenger, pubmed-meshheading:12742282-Receptors, Chemokine, pubmed-meshheading:12742282-Simvastatin, pubmed-meshheading:12742282-Time Factors
pubmed:year
2003
pubmed:articleTitle
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease.
pubmed:affiliation
Research Institute of Internal Medicine, Department of Cardiology, Rikshospitalet University Hospital, Oslo, Norway. torgun.wahre@klinmed.uio.no
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't